Biologics and Biosimilars Regulations and Registration in Brazil
According to the Drugs Sector Regulation Chamber (CMED) in 2022, the Brazilian pharmaceutical sector generated US $17.2 billion in sales […]
Biologics
Stay informed on the latest in biologic medicines with Biologics Insights. Explore trends, research updates, regulatory news, and innovations in therapeutic biologics, biosimilars, and advanced biologic treatments.
Biologics and Biosimilars Regulations and Registration in Australia (TGA)
The Australian healthcare system has transformed with the availability of biologic and biosimilar medications. The market for Australian biosimilars, which
Biologics and Biosimilars Regulations and Registration in Mexico (COFEPRIS)
Mexico is the second-largest drug market in Latin America, after Brazil. With a compound annual growth rate (CAGR) of 38.7%,